Nasal EPAP (Provent, Bongo) vs Nasal Stent: Which Stops Apnea Better?

Nasal EPAP vs Nasal Stent: The Core Difference

The choice between nasal EPAP vs nasal stent comes down to one fact most guides blur: the two devices solve airway collapse by opposite mechanisms. Nasal EPAP (expiratory positive airway pressure) uses small valves in your nostrils to create back-pressure when you breathe out, splinting the airway from inside the lungs. A nasal stent is a soft silicone channel that physically holds the nasal and throat airway open, like a tiny tunnel.

This difference decides who each device suits. EPAP needs clear nasal passages to build pressure, so it struggles when your nose is blocked. The stent works mechanically regardless of muscle tone, sleep position, or congestion. If you are still mapping your options, our evidence-based ranking of 9 CPAP alternatives gives the wider landscape, while this guide goes deep on these two mask-free contenders. To understand how the channel design works, see our explainer on the nasal stent for sleep apnea.

Both target the same severity band: habitual snoring and mild-to-moderate obstructive sleep apnea (OSA). OSA means the throat repeatedly collapses during sleep, briefly cutting off breathing. Neither device replaces CPAP for severe cases. Below, we compare them honestly on evidence, tolerability, cost, and the "blocked nose" question.

How Nasal EPAP Devices Like Provent and Bongo Work

Nasal EPAP is a tiny one-way valve that fits over or inside each nostril. When you inhale, air flows freely. When you exhale, the valve restricts airflow, building pressure that pushes back into your airway and keeps it from collapsing. Provent is a disposable adhesive patch worn one night each; Bongo Rx is a reusable nasal-pillow style valve.

The clinical evidence is moderate but real. A 2015 systematic review and meta-analysis by Riaz and colleagues in Sleep Disorders, pooling 920 patients across 18 studies, found nasal EPAP cut the apnea-hypopnea index (AHI, the count of breathing pauses per hour) by 53.2%, from 27.32 to 12.78 events per hour. Oxygen desaturation dropped 41.5%, and daytime sleepiness improved by 2.52 points on the Epworth scale. Crucially, patients without nasal obstruction responded best.

That last point is the catch. A 2016 study by Friedman and colleagues in The Laryngoscope confirmed patients without nasal obstruction improved more on Provent than those with a blocked nose. EPAP literally needs airflow resistance to work, so a stuffy nose undermines it.

How the Nasal Stent Works Differently

A nasal stent is a flexible silicone tube inserted into one nostril and extending toward the back of the throat. Instead of relying on pressure, it acts as a physical scaffold that mechanically keeps the nasal and nasopharyngeal airway open all night. Muscle relaxation, sleep position, and body weight do not collapse a channel that is already propped open.

Evidence comes from a 2021 study in Respiration (PubMed 33370725) of 71 patients with mild-to-moderate OSA (AHI 5 to 20). Nasal airway stent therapy produced a complete response in 25% and a partial response in 10%. About 30% did not tolerate the device because of side effects, an honest figure worth weighing. The mechanism makes the stent the logical choice for nasal and palatal snorers, and for congestion-prone sleepers whose noses are too blocked for an EPAP valve to build pressure.

The Back2Sleep nasal stent is a CE-certified Class I silicone device sold across Europe without a prescription. Its starter kit includes four sizes so you can find a comfortable fit. There is no electricity, no noise, and no tubing. For a direct severity comparison, our guide on the nasal stent vs CPAP for mild sleep apnea explains where each belongs.

Head-to-Head: Nasal EPAP vs Nasal Stent Comparison Table

The table below puts both devices side by side on the factors that decide real-world results. Note that AHI reduction figures come from different study populations and are not a direct trial comparison, so read them as indicative, not definitive.

Tolerability and Adherence: The Real Deciding Factor

Effectiveness only matters if you keep using a device. Reported nasal EPAP adherence looked strong at 80 to 94% in trials, but objective long-term use was lower. A 2011 study (PMC3190843) found only about two-thirds of eligible patients were still using their EPAP device at 12 months. Common complaints include difficulty exhaling against resistance, dry mouth, and nasal congestion.

The nasal stent has its own adaptation curve. Roughly 30% of users feel mild initial discomfort, and most need a 2-to-3-night adjustment period before insertion feels natural. The four-size starter kit exists precisely to reduce that drop-off by matching anatomy. Neither device is effortless, so honest expectations beat marketing promises.

This adherence problem is exactly why mask-free options matter in Europe. CPAP remains the gold standard for moderate-to-severe OSA, yet a 2016 review by Rotenberg and colleagues in the Journal of Otolaryngology - Head & Neck Surgery found CPAP non-adherence has held near 34% for two decades. Many people abandon the mask and then go untreated entirely, which is the worst outcome.

Which Device Should You Choose?

Your nose decides more than your AHI number does. The numbered guide below maps common situations to the better-fit device, assuming a clinician has already confirmed your severity.

Frequently Asked Questions